These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 29254275)

  • 1. Mesenchymal stem cells in idiopathic pulmonary fibrosis.
    Li X; Yue S; Luo Z
    Oncotarget; 2017 Nov; 8(60):102600-102616. PubMed ID: 29254275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis.
    Lan YW; Choo KB; Chen CM; Hung TH; Chen YB; Hsieh CH; Kuo HP; Chong KY
    Stem Cell Res Ther; 2015 May; 6(1):97. PubMed ID: 25986930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testing.
    Toonkel RL; Hare JM; Matthay MA; Glassberg MK
    Am J Respir Crit Care Med; 2013 Jul; 188(2):133-40. PubMed ID: 23306542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectivity of mesenchymal stem cells for bleomycin-induced pulmonary fibrosis: a systematic review and implication for clinical application.
    Zhao Y; Yan Z; Liu Y; Zhang Y; Shi J; Li J; Ji F
    Stem Cell Res Ther; 2021 Aug; 12(1):470. PubMed ID: 34420515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting the Role of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis: Cause or Solution.
    Samarelli AV; Tonelli R; Heijink I; Martin Medina A; Marchioni A; Bruzzi G; Castaniere I; Andrisani D; Gozzi F; Manicardi L; Moretti A; Cerri S; Fantini R; Tabbì L; Nani C; Mastrolia I; Weiss DJ; Dominici M; Clini E
    Front Pharmacol; 2021; 12():692551. PubMed ID: 34290610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulation by mesenchymal stem cells in treating human autoimmune disease-associated lung fibrosis.
    Liu M; Zeng X; Wang J; Fu Z; Wang J; Liu M; Ren D; Yu B; Zheng L; Hu X; Shi W; Xu J
    Stem Cell Res Ther; 2016 Apr; 7(1):63. PubMed ID: 27107963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte Growth Factor Is Required for Mesenchymal Stromal Cell Protection Against Bleomycin-Induced Pulmonary Fibrosis.
    Cahill EF; Kennelly H; Carty F; Mahon BP; English K
    Stem Cells Transl Med; 2016 Oct; 5(10):1307-1318. PubMed ID: 27388243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Applications of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis.
    Yang S; Liu P; Jiang Y; Wang Z; Dai H; Wang C
    Front Cell Dev Biol; 2021; 9():639657. PubMed ID: 33768094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat.
    Curley GF; Hayes M; Ansari B; Shaw G; Ryan A; Barry F; O'Brien T; O'Toole D; Laffey JG
    Thorax; 2012 Jun; 67(6):496-501. PubMed ID: 22106021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells for therapeutic applications in pulmonary medicine.
    Stabler CT; Lecht S; Lazarovici P; Lelkes PI
    Br Med Bull; 2015 Sep; 115(1):45-56. PubMed ID: 26063231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concise review: Mesenchymal stem cells for acute lung injury: role of paracrine soluble factors.
    Lee JW; Fang X; Krasnodembskaya A; Howard JP; Matthay MA
    Stem Cells; 2011 Jun; 29(6):913-9. PubMed ID: 21506195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte growth factor gene-modified mesenchymal stem cells reduce radiation-induced lung injury.
    Wang H; Yang YF; Zhao L; Xiao FJ; Zhang QW; Wen ML; Wu CT; Peng RY; Wang LS
    Hum Gene Ther; 2013 Mar; 24(3):343-53. PubMed ID: 23458413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis.
    Chambers DC; Enever D; Ilic N; Sparks L; Whitelaw K; Ayres J; Yerkovich ST; Khalil D; Atkinson KM; Hopkins PM
    Respirology; 2014 Oct; 19(7):1013-8. PubMed ID: 25039426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone Marrow-Derived Mesenchymal Stem Cells and Their Conditioned Medium Attenuate Fibrosis in an Irreversible Model of Unilateral Ureteral Obstruction.
    da Silva AF; Silva K; Reis LA; Teixeira VP; Schor N
    Cell Transplant; 2015; 24(12):2657-66. PubMed ID: 25695732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxic preconditioning enhances mesenchymal stromal cell lung repair capacity.
    Cruz FF; Rocco PR
    Stem Cell Res Ther; 2015 Jul; 6(1):130. PubMed ID: 26169784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-based therapies for the treatment of idiopathic pulmonary fibrosis (IPF) disease.
    Ghadiri M; Young PM; Traini D
    Expert Opin Biol Ther; 2016; 16(3):375-87. PubMed ID: 26593230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lights and Shadows in the Use of Mesenchymal Stem Cells in Lung Inflammation, a Poorly Investigated Topic in Cystic Fibrosis.
    Caretti A; Peli V; Colombo M; Zulueta A
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal Stem Cell-Derived Extracellular Vesicles as Idiopathic Pulmonary Fibrosis Microenvironment Targeted Delivery.
    Sang L; Guo X; Fan H; Shi J; Hou S; Lv Q
    Cells; 2022 Jul; 11(15):. PubMed ID: 35954166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of mesenchymal stem cells for pulmonary complications associated with preterm birth.
    Laube M; Stolzing A; Thome UH; Fabian C
    Int J Biochem Cell Biol; 2016 May; 74():18-32. PubMed ID: 26928452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-based therapy for idiopathic pulmonary fibrosis.
    Lu Q; El-Hashash AHK
    Stem Cell Investig; 2019; 6():22. PubMed ID: 31559309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.